Modeled DDIs for phenytoin
Overview of the modeled DDIs for phenytoin. Black arrow means sensitive victim in the specific metabolic pathway for phenytoin (CYP2C9 and CYP2C19) and itraconazole (CYP3A4). Red curve line means inhibition, e.g., fluconazole is a competitive inhibitor of phenytoin’s CYP2C9- and CYP2C19-mediated metabolism. Omeprazole inhibits the CYP2C19-mediated enzymatic conversion of phenytoin via competitive inhibition and mechanism-based inactivation (MBI). Green curve means the induction, e.g., phenytoin induces the CYP3A4-mediated enzymatic biotransformation of itraconazole.
Publication
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin (2023) Leyanis Rodriguez-Vera, et al. Pharmaceutics. 2023 Oct;15(10). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CYP2C9 | CYP2C9 | ncbigene_symbol | CYP2C9 | 1559 |
| Homo sapiens | Primates | CYP2C19 | CYP2C19 | ncbigene_symbol | CYP2C19 | 1557 |
| Homo sapiens | Primates | CYP3A4 | CYP3A4 | ncbigene_symbol | CYP3A4 | 1576 |
| Homo sapiens | Primates | MBI | MBI | ncbigene_synonym | SCARNA10 | 692148 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Phenytoin | phenytoin | 5,5-diphenylimidazolidine-2,4-dione | chebi:8107 | |
| Fluconazole | fluconazole | fluconazole | chebi:46081 | |
| Omeprazole | omeprazole | rac-5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole | chebi:7772 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|